Journals / Journal of the Turkish-German Gynecological Association / 2021 / Cilt: 22 - Sayı: 4

Perioperative considerations in the treatment of endometriosis

Pages
319–325
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article will discuss the perioperative considerations, diagnosis and treatment of endometriosis. (J Turk Ger Gynecol Assoc 2021; 22: 319-25)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Endometriosis is one of the most common benign diseases in women of reproductive age.
📊
Key Findings & Data:Nearly all gynecological offices and clinics will contain patients with endometriosis; the frequency and severity of the disease will vary from one setting to another.
💡
Conclusion & Impact:This article will discuss the perioperative considerations, diagnosis and treatment of endometriosis. (J Turk Ger Gynecol Assoc 2021; 22: 319-25)
🔬Design:Research Article
📍Scope:2021 Verileri
⚙️Variables:Domain Parameters

Abstract

Endometriosis is one of the most common benign diseases in women of reproductive age. Nearly all gynecological offices and clinics will contain patients with endometriosis; the frequency and severity of the disease will vary from one setting to another. Adjoining specialties, such as internal medicine, general medicine, surgery, urology, orthopedics, neurology and psychosomatic medicine, will be challenged directly or indirectly by various forms of endometriosis and its sequelae. The disease is characterized by pelvic pain, dysmenorrhea, dyspareunia and sterility. Even now, several years may elapse between the onset of the disease and its diagnosis. The diagnosis of endometriosis is complicated by the diversity of the symptoms. A precise documentation of the patient’s medical history and thorough diagnostic procedures are essential to establish a robust diagnosis. This article will discuss the perioperative considerations, diagnosis and treatment of endometriosis. (J Turk Ger Gynecol Assoc 2021; 22: 319-25)

🔖

Cite This Article

MAASS, N., ALKATOUT, I., METTLER, L., FREYTAG, D., PETERS, G., GITAS, G. (2022). Perioperative considerations in the treatment of endometriosis. Journal of the Turkish-German Gynecological Association, Cilt: 22 - Sayı: 4, 319–325. https://ajindex.com/articles/567388

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Olive DL, Schwartz LB. Endometriosis. N Engl J Med 1993; 328: 1759-69
  2. Alkatout I, Meinhold-Heerlein I, Keckstein J, Mettler L. Endometriosis: A concise practical guide to current diagnosis and treatment. J Turk Ger Gynecol Assoc 2018; 19: 173-5
  3. Alkatout I, Wedel T, Maass N. Combined treatment of endometriosis: radical yet gentle. Aktuelle Urol 2018; 49: 60-72
  4. Laganà AS, Vitale SG, Granese R, Palmara V, Ban Frangež H, Vrtačnik-Bokal E, et al. Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside. Expert Opin Drug Metab Toxicol 2017; 13: 593-6
  5. Fourquet J, Báez L, Figueroa M, Iriarte RI, Flores I. Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril 2011; 96: 107-12
  6. Hudelist G, Fritzer N, Thomas A, Niehues C, Oppelt P, Haas D, et al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 2012; 27: 3412-6
  7. Ballard KD, Seaman HE, de Vries CS, Wright JT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study--Part 1. BJOG 2008; 115: 1382-91
  8. Viganò P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 2004; 18: 177-200
  9. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996; 87: 321-7
  10. Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG, Barlow DH, et al. The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract 2001; 51: 541-7
  11. Grace VM, Zondervan KT. Chronic pelvic pain in New Zealand: prevalence, pain severity, diagnoses and use of the health services. Aust N Z J Pub Health 2004; 28: 369-75
  12. Laganà AS, Garzon S, Götte M, Viganò P, Franchi M, Ghezzi F, et al. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci 2019; 20: 5615
  13. Laganà AS, Salmeri FM, Ban Frangež H, Ghezzi F, Vrtačnik-Bokal E, Granese R. Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease. Gynecol Endocrinol 2020; 36: 441-4
  14. Filipchiuk C, Laganà AS, Beteli R, Ponce TG, Christofolini DM, Martins Trevisan C, et al. BIRC5/Survivin Expression as a Non-Invasive Biomarker of Endometriosis